Abstract: Lithofacies identification is crucial for characterizing subsurface reservoirs in the development and exploration of oil and gas resources. A common approach is to develop a lithofacies ...

The latest announcement is out from Silence Therapeutics ( (SLN)). On 5 March 2026, Silence Therapeutics reported fourth-quarter and full-year 2025 results, highlighting clinical progress across its ...

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Subscribe to Platinum Performance as of 11/29/24. Get access to powerful investment ...

Prospective multicenter data showed i31-SLNB <5% predicted risk yielded 2.6% SLN positivity, supporting NCCN-aligned omission of SLNB in appropriately selected melanoma patients. Marked discrimination ...

Shares of Silence Therapeutics PLC Sponsored ADR (SLN) have gained 34.4% over the past four weeks to close the last trading session at $5.78, but there could still be a solid upside left in the stock ...